Pre-approval Access for Janssen's COVID Vaccine VAC31518 for Treating Physician Use
Primary Purpose
Healthy
Status
No longer available
Phase
Locations
Study Type
Expanded Access
Intervention
Ad26.COV2.S
Sponsored by

About this trial
This is an expanded access trial for Healthy
Eligibility Criteria
Sites / Locations
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
NCT ID
NCT04817657
First Posted
March 24, 2021
Last Updated
March 24, 2021
Sponsor
Janssen Research & Development, LLC
1. Study Identification
Unique Protocol Identification Number
NCT04817657
Brief Title
Pre-approval Access for Janssen's COVID Vaccine VAC31518 for Treating Physician Use
Official Title
COVID Vaccine VAC31518 Pre-approval Access Study
Study Type
Expanded Access
2. Study Status
Record Verification Date
March 2021
Overall Recruitment Status
No longer available
Study Start Date
undefined (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Janssen Research & Development, LLC
4. Oversight
5. Study Description
Brief Summary
The purpose of this Pre-approval access (PAA) program is to provide VAC31518 (Ad26.CoV2.S) vaccine for the prevention of coronavirus disease-2019 (COVID-19) infection. This PAA program may be considered to protect participants against a serious/life-threatening diseases or conditions, where there are no alternative treatments available.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Healthy
7. Study Design
8. Arms, Groups, and Interventions
Intervention Type
Biological
Intervention Name(s)
Ad26.COV2.S
Other Intervention Name(s)
VAC31518, JNJ-78436735
Intervention Description
Participants will be administered 0.5 milliliter suspension of Ad26.COV2.S 1*10^11 virus particles per milliliter (vp/ml) as intramuscular injection.
10. Eligibility
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Janssen Research & Development, LLC Clinical Trial
Organizational Affiliation
Janssen Research & Development, LLC
Official's Role
Study Director
12. IPD Sharing Statement
Learn more about this trial
Pre-approval Access for Janssen's COVID Vaccine VAC31518 for Treating Physician Use
We'll reach out to this number within 24 hrs